APPLIED GENETIC TECHNOLOGIES CORP — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$325.0K

Net Income/Loss (FY2022)

-$68.9M

Total Assets (FY2022)

$66.7M

Total Equity (FY2022)

$29.5M

Cash Flows from Operating Activities (FY2022)

-$65.7M

Source: APPLIED GENETIC TECHNOLOGIES CORP 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.